99 results on '"Poupon A"'
Search Results
2. Antisaccades in Parkinson disease: A new marker of postural control?
3. Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis.
4. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
5. Quality of life in patients with primary biliary cirrhosis.
6. Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease.
7. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: An observational study.
8. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.
9. Liver alkaline phosphatase: A missing link between choleresis and biliary inflammation.
10. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI.
11. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis.
12. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression.
13. Determinants of outcome of compensated hepatitis C virus-related cirrhosis.
14. Circulating albumin messenger RNA in hepatocellular carcinoma: Results of a multicenter prospective study.
15. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: Results of a case-control study.
16. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis.
17. Serum bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy.
18. Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis.
19. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: Results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo.
20. Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception.
21. Patient-derived tumour xenografts as models for breast cancer drug development.
22. Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: A study of 156 consecutive patients.
23. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.
24. Pharmacokinetic-Pharmacodynamic Modeling of Manganese After a Single Intravenous Infusion of Mangafodipir in Patients With Acute Alcoholic Hepatitis.
25. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: A prospective magnetic resonance imaging and histological study.
26. Primary biliary cirrhosis.
27. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
28. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
29. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology.
30. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis.
31. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.
32. Chronic liver injury during obstructive sleep apnea.
33. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis.
34. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.
35. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.
36. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone.
37. Monitoring disease progression in CADASIL with diffusion magnetic resonance imaging: a study with whole brain histogram analysis.
38. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis.
39. Role of the supplementary motor area in motor deficit following medial frontal lobe surgery.
40. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: Results of a pilot study.
41. Diffusion tensor imaging study of subcortical gray matter in cadasil.
42. Single Alteration of p53 or E-cadherin Genes Can Alter the Surgical Resection Benefit in an Experimental Model of Colon Cancer.
43. Bile acid transport and regulating functions in the human biliary epithelium.
44. HBV GENOTYPIC RESISTANCE TO LAMIVUDINE IN KIDNEY RECIPIENTS AND HEMODIALYZED PATIENTS.
45. Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.
46. Phase I and Phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium.
47. Bile acids modulate the interferon signalling pathway.
48. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis.
49. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy.
50. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.